FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387409478> ?p ?o ?g. }

• W4387409478 endingPage "109946" @default.
• W4387409478 startingPage "109946" @default.
• W4387409478 abstract "This study tested the hypothesis that a novel combination of stereotactic ablation radiotherapy (SABR) and a cancer vaccine against fibroblast activation protein-alpha (FAPα) can suppress established tumor growth and impede potential metastasis.The poorly immunogenic metastatic mouse mammary carcinoma 4T1 was used as a model. Mice were randomly assigned to five treatment groups: (1) untreated control, (2) FAPα-based cancer vaccine, (3) SABR, (4) SABR + pCDH (lentiviral control vector), (5) SABR + FAPα-based cancer vaccine (SABR/FAPα-Vax). FAPα-based cancer vaccine were administered subcutaneously every week for a total of three treatments. SABR was delivered to the primary tumor by 3 × 8 Gy after the first vaccination.Consistent with the poorly immunogenic nature of 4T1, tumor-bearing mice receiving FAPα-based cancer vaccine or SABR monotherapy showed a modest reduction in tumor volume and increased animal lifespan. In contrast, SABR/FAPα-Vax was well-tolerated, significantly reduced tumor burden, and increased survival compared to monotherapy. The increased survival correlated with inhibition of extracellular matrix (ECM) production, tumor vascularization and lymphangiogenesis. SABR/FAPα-Vax also resulted in an abscopal effect capable of eliminating lung metastases. SABR/FAPα-Vax recruited and activated CD8 + T cells to attack tumor cells and FAPα + stromal cells, and initiated suppressor cell reprogramming, including facilitating macrophage polarization toward an anti-tumor (M1) state, as well as depleting myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs).These findings provide a novel therapeutic combination of radiation and FAPα-based cancer vaccine with promising results against poorly immunogenic metastatic cancer. This study may pave the way to overcome the therapeutic resistance caused by FAPα + CAFs." @default.
• W4387409478 created "2023-10-07" @default.
• W4387409478 creator A5000239527 @default.
• W4387409478 creator A5010262339 @default.
• W4387409478 creator A5024628055 @default.
• W4387409478 creator A5042380657 @default.
• W4387409478 creator A5048693726 @default.
• W4387409478 creator A5056588891 @default.
• W4387409478 creator A5058405537 @default.
• W4387409478 creator A5080879713 @default.
• W4387409478 date "2023-12-01" @default.
• W4387409478 modified "2023-10-18" @default.
• W4387409478 title "Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer" @default.
• W4387409478 cites W1952391983 @default.
• W4387409478 cites W2002968221 @default.
• W4387409478 cites W2048253455 @default.
• W4387409478 cites W2086834665 @default.
• W4387409478 cites W2088110734 @default.
• W4387409478 cites W2117878645 @default.
• W4387409478 cites W2154932340 @default.
• W4387409478 cites W2285824369 @default.
• W4387409478 cites W2299264726 @default.
• W4387409478 cites W2410079292 @default.
• W4387409478 cites W2786031287 @default.
• W4387409478 cites W2790543400 @default.
• W4387409478 cites W2801279436 @default.
• W4387409478 cites W2801372304 @default.
• W4387409478 cites W2899901789 @default.
• W4387409478 cites W2954764274 @default.
• W4387409478 cites W2975078545 @default.
• W4387409478 cites W2980005092 @default.
• W4387409478 cites W2985371979 @default.
• W4387409478 cites W2986162201 @default.
• W4387409478 cites W3003058300 @default.
• W4387409478 cites W3026844837 @default.
• W4387409478 cites W3111054862 @default.
• W4387409478 cites W3127051356 @default.
• W4387409478 cites W3207246837 @default.
• W4387409478 cites W4200111279 @default.
• W4387409478 cites W4210414550 @default.
• W4387409478 cites W4291993576 @default.
• W4387409478 cites W4300690596 @default.
• W4387409478 cites W4315754639 @default.
• W4387409478 doi "https://doi.org/10.1016/j.radonc.2023.109946" @default.
• W4387409478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37806560" @default.
• W4387409478 hasPublicationYear "2023" @default.
• W4387409478 type Work @default.
• W4387409478 citedByCount "0" @default.
• W4387409478 crossrefType "journal-article" @default.
• W4387409478 hasAuthorship W4387409478A5000239527 @default.
• W4387409478 hasAuthorship W4387409478A5010262339 @default.
• W4387409478 hasAuthorship W4387409478A5024628055 @default.
• W4387409478 hasAuthorship W4387409478A5042380657 @default.
• W4387409478 hasAuthorship W4387409478A5048693726 @default.
• W4387409478 hasAuthorship W4387409478A5056588891 @default.
• W4387409478 hasAuthorship W4387409478A5058405537 @default.
• W4387409478 hasAuthorship W4387409478A5080879713 @default.
• W4387409478 hasConcept C106159729 @default.
• W4387409478 hasConcept C121608353 @default.
• W4387409478 hasConcept C126322002 @default.
• W4387409478 hasConcept C143998085 @default.
• W4387409478 hasConcept C162324750 @default.
• W4387409478 hasConcept C187625094 @default.
• W4387409478 hasConcept C502942594 @default.
• W4387409478 hasConcept C509974204 @default.
• W4387409478 hasConcept C71924100 @default.
• W4387409478 hasConcept C85393063 @default.
• W4387409478 hasConcept C91602232 @default.
• W4387409478 hasConcept C96232424 @default.
• W4387409478 hasConceptScore W4387409478C106159729 @default.
• W4387409478 hasConceptScore W4387409478C121608353 @default.
• W4387409478 hasConceptScore W4387409478C126322002 @default.
• W4387409478 hasConceptScore W4387409478C143998085 @default.
• W4387409478 hasConceptScore W4387409478C162324750 @default.
• W4387409478 hasConceptScore W4387409478C187625094 @default.
• W4387409478 hasConceptScore W4387409478C502942594 @default.
• W4387409478 hasConceptScore W4387409478C509974204 @default.
• W4387409478 hasConceptScore W4387409478C71924100 @default.
• W4387409478 hasConceptScore W4387409478C85393063 @default.
• W4387409478 hasConceptScore W4387409478C91602232 @default.
• W4387409478 hasConceptScore W4387409478C96232424 @default.
• W4387409478 hasFunder F4320318548 @default.
• W4387409478 hasFunder F4320321001 @default.
• W4387409478 hasFunder F4320329861 @default.
• W4387409478 hasLocation W43874094781 @default.
• W4387409478 hasLocation W43874094782 @default.
• W4387409478 hasOpenAccess W4387409478 @default.
• W4387409478 hasPrimaryLocation W43874094781 @default.
• W4387409478 hasRelatedWork W1930362318 @default.
• W4387409478 hasRelatedWork W2171123343 @default.
• W4387409478 hasRelatedWork W2549182546 @default.
• W4387409478 hasRelatedWork W2767930639 @default.
• W4387409478 hasRelatedWork W2802937241 @default.
• W4387409478 hasRelatedWork W2898475551 @default.
• W4387409478 hasRelatedWork W3028959428 @default.
• W4387409478 hasRelatedWork W4221031915 @default.
• W4387409478 hasRelatedWork W4283714926 @default.
• W4387409478 hasRelatedWork W4307152771 @default.

• next